Author

Luara Teófilo Pignati

Observed institution: Universidade Federal de Mato Grosso

OpenAlex ID: A5033844985

Efficacy and safety of Butantan-DV in participants aged 2–59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil

2024 · Mauricio L Nogueira, Monica A T Cintra, et al. · The Lancet Infectious Diseases · 70

Risk factors for hepatitis C virus infection in Inland Brazil: An analysis of pooled epidemiological sectional studies

2012 · Francisco José Dutra Souto, Cor Jésus Fernandes Fontes, et al. · Journal of Medical Virology · 8

Works count: 2

Citation count: 77

H-index: 2

I10-index: 1